Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Achieve Life Sciences to present 52-week cytisinicline efficacy data from ORCA-OL smoking, e-cigarette cessation trial at CHEST 2026

Achieve Life Sciences to present 52-week cytisinicline efficacy data from ORCA-OL smoking, e-cigarette cessation trial at CHEST 2026

BitgetBitget2026/09/28 12:31
  • Achieve Life Sciences flagged new 52-week trial data on cytisinicline for smoking and e-cigarette cessation for presentation at CHEST 2026.
  • Results from the open-label ORCA-OL study are scheduled for Oct. 20, 2026, indicating sustained abstinence during year-long treatment.
  • The trial enrolled 475 adults who previously participated in earlier cytisinicline studies and continued to smoke or vape daily.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Achieve Life Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609280830PRIMZONEFULLFEED9834664) on September 28, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

BUZZ - TSMC shares rise 3% after Elon Musk confirms negotiations on the TeraFab project

October 5th – Elon Musk confirmed discussions with TSMC (2330.TW), prompting a 3% increase in the company’s share price. The Taiwan Stock Exchange Weighted Index (.TWII) rose by 2.4%. Tesla (TELA.O) and SpaceX (SPCX.O) CEO Musk stated on Saturday via X platform that TSMC and his chip manufacturing project, Terafab, have discussed potential collaboration. In response to a post on X featuring a screenshot of an article titled “TSMC is exploring plans to cooperate with Elon Musk’s TeraFab,” Musk replied on Saturday: "It is only at the discussion stage for now, but something could result." TSMC’s share price has increased by 66% so far this year. (For the convenience of non-English speakers, Reuters automatically translates its reports into several other languages. As automated translations may contain errors or lack needed context, Reuters does not guarantee the accuracy of the automated translated texts. They are provided merely for the convenience of readers. Reuters bears no responsibility for any damage or losses resulting from the use of the automated translation function.)

路透社•2026/10/05 02:16

10-Yr Benchmark Govt Yields - Germany vs Other Nations

Current Spread in Yield Basis Points Germany 3.475 % Australia 5.347 % 187.2 Belgium 4.339 % 86.4 Canada 3.944 % 46.9 Denmark 3.268 % -20.7 France 4.866 % 139.1 Italy 4.604 % 113.0 Japan 3.089 % -38.6 Netherlands 3.577 % 10.2 Spain 4.087 % 61.2 Sweden 3.146 % -32.9 U.K. 5.369 % 189.4 U.S. 5.256 % 178.1 Source: Tullett Prebon via FactSet (END) Dow Jones Newswires October 04, 2026 22:10 ET (02:10 GMT)

Dow Jones•2026/10/05 02:10